MAIER PAUL V
Insider CIK 1182615 · PURE Director · APRI Director · SQNM Chief Financial Officer · MBVX Director · TLON Director · ISCO Director · RTTR Director · ETON Director · AMAM Director · AMAM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ISCO International Stem Cell CO | D To issuer deriv | 2026-09-16 | 2026-09-17 | 30,000 | — | $0 | 0 | SEC↗ |
| ISCO International Stem Cell CO | D To issuer deriv | 2026-09-16 | 2026-09-17 | 30,000 | — | $0 | 0 | SEC↗ |
| ISCO International Stem Cell CO | S Sale | 2026-09-11 | 2026-09-15 | 32,802 | $0.32 | $10.5K | 0 | SEC↗ |
| ISCO International Stem Cell CO | S Sale | 2026-09-11 | 2026-09-15 | 32,802 | $0.32 | $10.5K | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-28 | 50,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-31 | 12,500 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-31 | 50,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 36,387 | $58.64 | $2.13M | 73,358 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 13,485 | $60.21 | $811.9K | 59,873 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 128 | $61.77 | $7.9K | 59,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-28 | 50,000 | $3.78 | $189.0K | 109,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 36,387 | $58.64 | $2.13M | 73,358 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-31 | 50,000 | $3.78 | $189.0K | 109,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 128 | $61.77 | $7.9K | 59,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 13,485 | $60.21 | $811.9K | 59,873 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-31 | 12,500 | $7.31 | $91.4K | 72,245 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-28 | 50,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 128 | $61.77 | $7.9K | 59,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 13,485 | $60.21 | $811.9K | 59,873 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-28 | 36,387 | $58.64 | $2.13M | 73,358 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-28 | 50,000 | $3.78 | $189.0K | 109,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-31 | 12,500 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise deriv | 2026-08-28 | 2026-08-31 | 50,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-31 | 12,500 | $7.31 | $91.4K | 72,245 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 128 | $61.77 | $7.9K | 59,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 13,485 | $60.21 | $811.9K | 59,873 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 36,387 | $58.64 | $2.13M | 73,358 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | M Exercise | 2026-08-28 | 2026-08-31 | 50,000 | $3.78 | $189.0K | 109,745 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award deriv | 2026-06-11 | 2026-06-23 | 182,584 | — | $0 | 182,584 | SEC↗ |
| ISCO International Stem Cell CO | A Award deriv | 2026-06-11 | 2026-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 7,757 | — | $0 | 294,253 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 12,196 | — | $0 | 286,496 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2025-06-17 | 2025-06-20 | 532,786 | — | $0 | 532,786 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2025-06-17 | 2025-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2024-06-11 | 2024-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2024-06-11 | 2024-06-13 | 361,111 | — | $0 | 361,111 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 15,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 12,142 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | D To issuer deriv | 2024-03-07 | 2024-03-07 | 30,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 30,000 | — | $0 | 164,555 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2023-06-14 | 2023-06-16 | 445,205 | — | $0 | 445,205 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2023-06-14 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award | 2023-06-07 | 2023-06-09 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2023-03-03 | 2023-03-03 | 25,000 | — | $0 | 134,555 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 210,000 | — | $0 | 210,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 105,000 | — | $0 | 105,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | D To issuer deriv | 2023-01-27 | 2023-01-31 | 105,000 | — | $0 | 0 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | D To issuer deriv | 2023-01-27 | 2023-01-31 | 210,000 | — | $0 | 0 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2022-06-09 | 2022-06-10 | 139,264 | — | $0 | 139,264 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2022-06-09 | 2022-06-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2022-02-07 | 2022-02-28 | 50,000 | — | $0 | 109,555 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2021-06-09 | 2021-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2021-06-09 | 2021-06-11 | 183,481 | — | $0 | 183,481 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 19,655 | — | $0 | 59,555 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2020-06-23 | 2020-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2020-06-23 | 2020-06-24 | 46,428 | — | $0 | 46,428 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2020-06-23 | 2020-06-26 | 92,857 | — | $0 | 92,857 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2020-03-12 | 2020-03-16 | 27,400 | — | $0 | 27,400 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2020-01-15 | 2020-01-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2019-06-03 | 2019-06-05 | 71,982 | — | $0 | 71,982 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2019-06-03 | 2019-06-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | S Sale | 2019-04-18 | 2019-04-22 | 1,350 | $1.25 | $1.7K | 31,710 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2019-02-20 | 2019-03-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2019-02-06 | 2019-02-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2018-11-15 | 2018-11-15 | 5,000 | $6.00 | $30.0K | 59,745 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2018-06-21 | 2018-06-25 | 38,462 | — | $0 | 38,462 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2018-06-21 | 2018-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2018-06-21 | 2018-06-25 | 8,655 | — | $0 | 8,655 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2018-04-02 | 2018-04-03 | 513 | — | $0 | 0 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2018-04-02 | 2018-04-04 | 513 | — | $0 | 0 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2018-04-02 | 2018-04-03 | 513 | — | $0 | 23,462 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2018-04-02 | 2018-04-04 | 513 | — | $0 | 23,063 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2018-03-30 | 2018-04-03 | 11,054 | — | $0 | 11,054 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2018-02-21 | 2018-02-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | S Sale | 2018-01-24 | 2018-01-24 | 17,999 | $0.84 | $15.1K | 68,314 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2018-01-23 | 2018-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | S Sale | 2018-01-23 | 2018-01-24 | 17,449 | $0.87 | $15.2K | 86,313 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2018-01-08 | 2018-01-12 | 100,000 | — | $0 | 1,543 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2018-01-08 | 2018-01-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2018-01-04 | 2018-01-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2017-12-29 | 2018-01-02 | 10,350 | — | $0 | 10,350 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-10-02 | 2017-10-04 | 75,790 | — | $0 | 75,790 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2017-09-29 | 2017-10-02 | 8,830 | — | $0 | 8,830 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-09-15 | 2017-09-18 | 24,210 | — | $0 | 24,210 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2017-06-30 | 2017-07-05 | 14,254 | — | $0 | 14,254 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-06-12 | 2017-06-14 | 20,000 | $1.57 | $31.4K | 20,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2017-05-31 | 2017-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-05-19 | 2017-05-23 | 50,000 | $1.80 | $90.0K | 50,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2017-04-02 | 2017-04-04 | 1,543 | — | $0 | 1,543 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2017-04-02 | 2017-04-04 | 1,543 | — | $0 | 3,762 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2017-03-31 | 2017-04-03 | 4,642 | — | $0 | 33,060 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2017-01-05 | 2017-01-06 | 11,250 | — | $0 | 13,854 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-01-01 | 2017-01-03 | 4,100 | $3.38 | $13.9K | 4,100 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-12-30 | 2016-12-30 | 7,523 | — | $0 | 28,418 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2016-11-29 | 2016-11-30 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-10-13 | 2016-10-14 | 1,334 | — | $0 | 20,895 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-09-30 | 2016-10-03 | 10,715 | $0.34 | $3.6K | 26,039 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-09-30 | 2016-09-30 | 4,391 | — | $0 | 19,561 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2016-08-29 | 2016-08-30 | 4,100 | $5.00 | $20.5K | 4,100 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-06-30 | 2016-07-01 | 9,074 | $0.40 | $3.6K | 15,324 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-06-30 | 2016-06-30 | 4,042 | — | $0 | 15,170 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2016-06-29 | 2016-07-28 | 35,000 | $0.55 | $19.3K | 35,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2016-05-17 | 2016-05-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award | 2016-04-05 | 2016-04-07 | 6,250 | $0.58 | $3.6K | 6,250 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2016-04-04 | 2016-04-05 | 11,417 | — | $0 | 22,833 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2016-04-04 | 2016-04-05 | 11,417 | — | $0 | 16,417 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-03-31 | 2016-04-04 | 2,104 | — | $0 | 11,128 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2016-01-04 | 2016-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-12-31 | 2015-12-31 | 2,403 | — | $0 | 9,024 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2015-10-13 | 2015-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-09-30 | 2015-10-02 | 2,011 | — | $0 | 6,621 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-08-26 | 2015-08-27 | 35,000 | $1.52 | $53.2K | 35,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-06-30 | 2015-07-02 | 181,767 | — | $0 | 691,449 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | P Buy | 2015-05-29 | 2015-06-02 | 5,000 | $2.30 | $11.5K | 5,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2015-04-08 | 2015-04-08 | 99,946 | — | $0 | 509,682 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-04-03 | 2015-04-03 | 76,958 | — | $0 | 409,736 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-04-02 | 2015-04-03 | 34,250 | — | $0 | 34,250 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-04-02 | 2015-04-03 | 34,250 | $2.30 | $78.8K | 34,250 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2015-01-02 | 2015-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2014-10-02 | 2014-10-02 | 49,653 | — | $0 | 332,778 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2014-05-08 | 2014-05-12 | 40,000 | — | $0 | 283,125 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2014-03-21 | 2014-03-25 | 162,500 | — | $0 | 243,125 | SEC↗ |
| SQNM SEQUENOM INC | D To issuer deriv | 2014-02-10 | 2014-02-12 | 7,150 | — | $0 | 67,450 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2014-02-10 | 2014-02-12 | 7,150 | — | $0 | 66,927 | SEC↗ |
| SQNM SEQUENOM INC | F Tax w/h | 2014-02-10 | 2014-02-12 | 3,138 | $2.34 | $7.3K | 63,789 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2014-02-06 | 2014-02-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2014-02-01 | 2014-02-04 | 46,000 | — | $0 | 74,600 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2014-02-01 | 2014-02-04 | 60,129 | — | $0 | 60,129 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2014-02-01 | 2014-02-04 | 32,871 | — | $0 | 32,871 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2014-01-02 | 2014-01-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 12,500 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 47,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 47,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 47,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 12,500 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 2,500 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 10,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer | 2013-07-17 | 2013-07-18 | 1,750 | — | $0 | 0 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2013-06-20 | 2013-06-21 | 40,000 | — | $0 | 242,500 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2013-06-19 | 2013-06-20 | 6,666 | — | $0 | 59,777 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-02-01 | 2013-02-05 | 28,600 | — | $0 | 28,600 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-02-01 | 2013-02-05 | 40,517 | — | $0 | 40,517 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-02-01 | 2013-02-05 | 16,683 | — | $0 | 16,683 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2013-02-01 | 2013-03-13 | 28,600 | — | $0 | 28,600 | SEC↗ |
| TLON Talon Therapeutics, Inc. | A Award deriv | 2013-01-25 | 2013-01-29 | 47,000 | — | $0 | 47,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2013-01-25 | 2013-01-29 | 162,500 | — | $0 | 202,500 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2013-01-07 | 2013-01-08 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 1,400 | $2.86 | $4.0K | 5,600 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.86 | $572 | 4,200 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 500 | $2.86 | $1.4K | 4,000 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.85 | $570 | 3,500 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 700 | $2.84 | $2.0K | 2,400 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 600 | $2.83 | $1.7K | 1,700 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 700 | $2.83 | $2.0K | 1,100 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.82 | $564 | 400 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.81 | $562 | 200 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 500 | $2.86 | $1.4K | 6,100 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 100 | $2.87 | $287 | 6,200 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 1,500 | $2.87 | $4.3K | 7,700 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 900 | $2.88 | $2.6K | 8,600 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.89 | $578 | 8,800 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 200 | $2.89 | $578 | 9,000 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 100 | $2.91 | $291 | 9,100 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 500 | $2.91 | $1.5K | 9,600 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 400 | $3.00 | $1.2K | 10,000 | SEC↗ |
| SQNM SEQUENOM INC | P Buy | 2012-08-01 | 2012-08-02 | 900 | $2.84 | $2.6K | 3,300 | SEC↗ |
| PURE PURE BIOSCIENCE, INC. | A Award | 2012-07-31 | 2012-08-02 | 13,710 | $0.38 | $5.2K | 69,110 | SEC↗ |
| APRI APRICUS BIOSCIENCES, INC. | A Award deriv | 2012-06-01 | 2012-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2012-05-29 | 2012-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TLON Talon Therapeutics, Inc. | A Award deriv | 2012-02-17 | 2012-02-22 | 47,000 | — | $0 | 47,000 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2012-02-07 | 2012-02-08 | 111,638 | — | $0 | 111,638 | SEC↗ |
| SQNM SEQUENOM INC | A Award deriv | 2012-02-07 | 2012-02-08 | 22,362 | — | $0 | 22,362 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2012-02-07 | 2012-02-08 | 888 | — | $0 | 51,998 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2012-02-07 | 2012-02-08 | 888 | — | $0 | 52,886 | SEC↗ |
| SQNM SEQUENOM INC | A Award | 2012-02-07 | 2012-02-08 | 225 | — | $0 | 53,111 | SEC↗ |